Interestingly, this is the first report demonstrating that PLA1A mRNA expression, with a cut-off value of 0.072 and serum PLA1A levels of 40.91 μg/L could be used to discriminate naïve melanoma samples from advanced melanoma samples, with a sensitivity of 91% and a specificity of 57%. This evidence concerns the gene PLA1A and melanoma.